London, UK - Despite inducing only a modest drop in blood pressure (BP), the ACE inhibitor ramipril (Altace® - Monarch Pharmaceuticals) caused a significant reduction in cardiovascular death, MI, or ...
Preclinical and clinical data suggest that angiotensin-converting-enzyme inhibitors (ACEIs) may reduce the risk for ischemic events independent of the drugs' blood pressure-lowering effects. This is ...
Angiotensin-converting-enzyme (ACE) inhibitors were developed for the treatment of hypertension. Subsequently they became indicated for several cardiovascular and renal conditions. ACE inhibitors play ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback